MagForce AG Co-Sponsors Brain Cancer Patient Event Of University Hospital Münster Held On Occasion Of The 2017 World Brain Tumor Day
MagForce AG Co-Sponsors Brain Cancer Patient Event of University Hospital Münster
held on occasion of the 2017 World Brain Tumor Day
Under this year's slogan "Wir rocken das! Psychoonkologische Begleitung mit viel Schwung! (We will rock that! Dynamic psycho-oncological support program)!" the event will, through a series of dance and creative workshops, feature engaging exercises aimed at involving all senses. Creative arts therapies are the focal point of the program. Such complimentary therapies have been found to help manage the emotional and psychological side effects that often result from cancer diagnosis and treatment. Furthermore, participants will have the opportunity for one-on-one discussions with experts in the fields of individual coaching, art therapy and psycho-oncology throughout the day. The event will take place at the premises of the University Münster Sports Center in Münster,
The University Hospital Münster was the second medical center in
For further information regarding program (German only) and registration, please visit: http://klinikum.uni-muenster.de/index.php?id=hirntumorzentrum-aktuell
About the World Brain Tumor Day
This commemoration day was initialised by the Deutsche Hirntumorhilfe e.V. (
Role of NanoTherm(R) Therapy in the Treatment of Brain Tumors
NanoTherm(R) therapy is an intratumoral thermotherapy which aims to help patients with brain tumors. It can be used as a monotherapy or in combination with radiotherapy and/or chemotherapy to enhance their effectiveness.
With NanoTherm(R) therapy, the magnetic fluid injected into a tumor is heated through a very fast alternating magnetic field. Through the heat, tumor cells are either destroyed or sensitized for additional therapies such as radiotherapy and/or chemotherapy; thus, the efficacy of the additional therapies is improved.
About
NanoTherm(R), NanoPlan(R), and NanoActivator(R) are components of the therapy and have received EU-wide regulatory approval as medical devices for the treatment of brain tumors.
For more information, please visit: www.magforce.com.
Get to know our Technology: video (You Tube)
Stay informed and subscribe to our mailing list.
Disclaimer
This release may contain forward-looking statements and information which may be identified by formulations using terms such as "expects", "aims", "anticipates", "intends", "plans", "believes", "seeks", "estimates" or "will". Such forward-looking statements are based on our current expectations and certain assumptions, which may be subject to a variety of risks and uncertainties. The results actually achieved by
Contact:
Vice President
Communications & Investor Relations
T +49-30-308380-77